Abstract
Studies both in vivo1,2 and in vitro1–5 have shown that substituted benzimidazoles inhibit the stimulation of acid secretion produced by dibutyryl cyclic AMP and histamine. Furthermore, the results differ from those produced by H2 antagonists and anticholinergic agents in that the inhibition is not competitive, and the site of action is intracellular and peripheral to that of dibutyryl cyclic AMP. To investigate the biochemical mechanism of action of substituted benzimidazoles, one such compound, H 149/94 (2-{ [2-(3-methyl)pyridyl-methyl]-sulphinyl]-5-methoxycarbonyl-6-methylbenzimidazol), has been tested either directly on an (H+ + K+) ATPase isolated from pig and human gastric mucosa or on the function of this enzyme in gastric glands isolated from rabbit and human gastric mucosa. (H+ + K+)ATPase6,7, which has only been found at the secretory surface of the parietal cell8, catalyses a one-to-one exchange of protons and potassium ions9–11. It is possibly the proton pump within the gastric mucosa, and may thus be the terminal or one of the terminal steps of the acid secretory process12,13. We show here that H 149/94 inhibits (H+ + K+)ATPase, which may explain its inhibitory action on acid secretion in vitro and in vivo. Because of the unique distribution and properties of the (H+ + K+) ATPase, the inhibitory action of H 149/94 on this enzyme may be a highly selective clinical means of suppressing the acid secretory process.
Similar content being viewed by others
References
Fellenius, E. et al. in Hydrogen Ion Transport in Epithelia (eds Schulz, I., Sachs, G., Forte J & Ullrich, K. J.) 193–202 (Elsevier, Amsterdam, 1980).
Olbe, L., Sjöstrand, S.-E. & Fellenius, E. in Gastrins and the Vagus (eds Rehfeld, J. F. & Amdrup, E.) 245–250 (Academic, New York, 1979).
Sjöstrand, S.-E., Ryberg, B. & Olbe, L. Acta physiol. scand. spec. Suppl., 181–185 (1978).
Olbe, L. et al. Scand. J. Gastroenterol. Suppl. 55, 131–133 (1979).
Fellenius, E. et al. in Hormone Receptors in Digestion and Nutrition (eds Rosselin, G., Fromageot, P . & Bonfils, S.) 355–360 (Elsevier, Amsterdam, 1979).
Lee, J., Simpson, G. & Scholes, P. Biochem. biophys. Res. Commun. 60, 825–832 (1974).
Ray, T. K. & Forte, J. G. Biochim. biophys. Acta 443, 451–467 (1976).
Saccomani, G. et al. J. Cell Biol 83, 271–283 (1979).
Shackman, R., Schwartz, A., Saccomani, G. & Sachs, G. J. Membrane Biol. 32, 361–381 (1977).
Sachs, G., Chang, H. M., Rabon, E., Schackman, R. & Saccomani, G. J. biol. Chem. 251, 7690–7698 (1976).
Chang, H., Saccomani, G., Rabon, E., Shackman, R. & Sachs, G. Biochim. biophys. Acta 464, 313–327 (1977).
Sachs, G. et al. Gastroenterology 71, 931–931 (1977).
Forte, J. G. & Lee, H. C. Gastroenterology 73, 921–927 (1977).
Berglindh, T. & Öbrink, K.-J. Acta physiol. scand. 96, 150–159 (1976).
Berglindh, T. Biochim. biophys. Acta 464, 217–233 (1977).
Chew, C. S., Hersey, S. J., Sachs, G. & Berglindh, T. Am. J. Physiol. 238, 312–320 (1980).
Berglindh, T., Helander, H. F. & Sachs, G. Scand. J. Gastroenterol. Suppl. 55, 7–15 (1979).
Berglindh, T., Dibona, D. R., Ito, S. & Sachs, G. Am. J. Physiol. 238, G 165–G 176 (1980).
Soll, A., Am. J. Physiol. 238, G 366–G 375 (1980).
Saccomani, G., Stewart, H. B., Shaw, D., Lewin, M. & Sachs, G. Biochim. biophys. Acta 465, 311–330 (1977).
Rabon, E., Chang, H. & Sachs, G. Biochemistry 17, 3345–3353 (1978).
Fiske, C. H. & Subbarow, Y. J. Biol. Chem. 66, 375–100 (1925).
Mårdh, S. Biochim. biophys. Acta 391, 448–463 (1975).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fellenius, E., Berglindh, T., Sachs, G. et al. Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+ + K+) ATPase. Nature 290, 159–161 (1981). https://doi.org/10.1038/290159a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/290159a0
- Springer Nature Limited
This article is cited by
-
Insights into Dietary Switch in Cetaceans: Evidence from Molecular Evolution of Proteinases and Lipases
Journal of Molecular Evolution (2020)
-
Deficient Active Transport Activity in Healing Mucosa After Mild Gastric Epithelial Damage
Digestive Diseases and Sciences (2020)
-
Optimal Omeprazole Dosing and Symptom Control: A Randomized Controlled Trial (OSCAR Trial)
Digestive Diseases and Sciences (2019)
-
The Gastric and Intestinal Microbiome: Role of Proton Pump Inhibitors
Current Gastroenterology Reports (2017)
-
Chromium(III)-salen complex nanoparticles on AlPO4: as an efficient heterogeneous and reusable nanocatalyst for mild synthesis of highly functionalized piperidines, 2-arylbenzimidazoles, and 2-arylbenzothiazoles
Journal of the Iranian Chemical Society (2017)